Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights ...

If you're an individual retail investor searching for healthcare stocks you can buy and hold for at least 20 years, here are ...

Vertex Pharmaceuticals’ povetacicept – This BAFF/APRIL dual-pathway inhibitor has emerged as a strong contender in the MN pipeline. Nephrologists view the differentiated mechanism as addressing core ...

Roche’s phase III ALLEGORY study of Gazyva/Gazyvaro in adults with systemic lupus erythematosus meets its primary endpoint: Basel Tuesday, November 4, 2025, 12:00 Hrs [IST] Roch ...

Get insights from Vertex Pharmaceuticals' Q3 2025 earnings call—revenue growth, pipeline milestones, and outlook for ALYFTREK, CASGEVY, and JOURNAVX.

Investors want their money to grow in some shape, form, or fashion with every stock they buy. However, I understand that ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the most profitable biotech stocks to buy. H.C. Wainwright ...

Vertex Pharmaceuticals Incorporated remains a leader in CF treatments, fueling robust cash flow and pipeline expansions.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from the Phase III ALLEGORY study of Gazyva® ...

Skin-whitening creams containing mercury pose a serious threat to kidney health. These products, often sold online and ...